Current status:
Cancelled Post Market
Current status date:
2017-07-26
DIN:
00433519
Electronic product monograph is not available
Company:
ALLERGAN INC
300
1380 Rodick Road
Markham
Ontario
Canada
L3R 4G5
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
Anatomical Therapeutic Chemical (ATC):
See footnote 4
S01GA51 NAPHAZOLINE, COMBINATIONS
List of active ingredient(s)
Active ingredient(s) |
Strength |
ANTAZOLINE PHOSPHATE
|
.5 %
|
NAPHAZOLINE HYDROCHLORIDE
|
.05 %
|